Wednesday, September 9, 2020
11:56 AM EST – Nuvo Pharmaceuticals Inc. : Announced that its wholly owned subsidiary, Aralez Pharmaceuticals Canada Inc. (Aralez Canada) has launched Suvexx into the approximately $130-million Canadian prescription acute migraine market. Nuvo Pharmaceuticals Inc. (T.NRI) shares were down $0.01 at 0.75.
Stocks in Play: Nuvo Pharmaceuticals Inc., Wed, 09 Sep 2020 12:00:02 EST